Proactive tobacco treatment offering free nicotine replacement therapy and telephone counselling for socioeconomically disadvantaged smokers: a randomised clinical trial.

What Was Tested

This randomized controlled trial looks at Therapeutic nicotine (patch, non-peptide).

Evidenced-based tobacco cessation treatments are underused, especially by socioeconomically disadvantaged smokers.

This contributes to widening socioeconomic disparities in tobacco-related morbidity and mortality.

Who Took Part

By PubMed's age tags, the people studied were teenagers, adults and middle-aged adults, both men and women.

The Offering Proactive Treatment Intervention trial tested the effects of a proactive outreach tobacco treatment intervention on population-level smoking abstinence and tobacco treatment use among a population-based sample of socioeconomically disadvantaged smokers.

Current smokers (n=2406), regardless of interest in quitting, who were enrolled in the Minnesota Health Care Programs, the state's publicly funded healthcare programmes for low-income populations, were randomly assigned to proactive outreach or usual care.

How the Study Was Run

In design terms this was a randomized study.

The participants were allocated by chance, so the Therapeutic nicotine (patch, non-peptide) group and the comparison group should start out alike.

The intervention comprised proactive outreach (tailored mailings and telephone calls) and free cessation treatment (nicotine replacement therapy and intensive, telephone counselling).

Usual care comprised access to a primary care physician, insurance coverage of Food and Drug Administration-approved smoking cessation medications, and the state's telephone quitline.

The primary outcome was self-reported 6-month prolonged smoking abstinence at 1 year and was assessed by follow-up survey.

What Was Measured

PubMed files the paper under topics including Counseling, Health Care Surveys, Minnesota, Poverty, Smoking Cessation, Telephone and Tobacco Use Cessation Devices.

The authors tagged it with the keywords Tobacco control.

What This Means in Plain Language

The paper is a randomized study of Therapeutic nicotine (patch, non-peptide).

Its findings take up roughly 5 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2016 (Thorax), a journal based in England.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.